Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Loyfolate
- Development stage
- Unknown
- Lead developer
- Lloyd Healthcare
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**Loyfolate** is an oral fixed-dose vitamin formulation marketed by Lloyd Healthcare. It contains **L-methylfolate**, **methylcobalamin**, and **pyridoxal 5-phosphate**, the active coenzyme forms of folate, vitamin B12, and vitamin B6, respectively. The product is used as nutritional and neurovascular support in conditions including diabetic peripheral neuropathy, hyperhomocysteinemia, endothelial dysfunction, and lower-extremity ulceration. Its components support one-carbon metabolism, homocysteine remethylation, erythropoiesis, DNA synthesis, and peripheral nerve function.
- Brand names
- Loyfolate
- Other names
- L-methylfolate + methylcobalamin + pyridoxal 5-phosphate
Beyond the preview
Go deeper on Loyfolate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Loyfolate.